الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 76 |  |  |
| | | from | 76 | | |
Abstract
Background: Uterine myomas, a major gynecologic problem among women in reproductive age, mostly asymptomatic and sometimes have symptoms, most common symptoms are abnormal uterine bleeding (AUB), infertility and pelvic discomfort. Minimally invasive treatment operations are the best option for the treatment of submucous uterine leiomyomas. Hysteroscopic myomectomy has a long track record in this field and has good results when patients have been selected properly. Objectives: In this study, the aim was to assess the possible impact of hysteroscopic myomectomy on ovarian function as estimated by short-term changes in serum AMH. Methods: AMH, FSH and E2 were measured on day 2-4 of the menstrual cycle. Blood samples were taken for measurement of serum AMH level one week before operation (baseline) and at one week, one month, and 3 months after operation. All AMH levels were measured in a single run via enzyme-linked immune sorbent assay (ELISA). Results: serum AMH level 3 months after hysteroscopic myomectomy was comparable to the AMH level before the operationConclusion: Hysteroscopic myomectomy has no adverse effect on ovarian reserve.